Despite the failure of the American Health Care Act, which included a provision to repeal the 2.3% device tax introduced under the Affordable Care Act, AdvaMed President and CEO Scott Whitaker said he’s confident Congress will find another way to get rid of the tax.
“We feel pretty good that if we move to another vehicle, whether its tax reform, [State Children’s Health Insurance Program] SCHIP reauthorization, tax extenders, that the Chairman and the leadership of the House—and the Senate, frankly—will support moving it to another vehicle,” Whitaker said April 11.
“I think in the second quarter or third quarter of this year, it’ll move to the appropriate vehicle. I’m pretty confident it’ll get done this year,” Whitaker added.
A standalone bill would have broad bipartisan support, Whitaker said. As evidence, he cited legislation to repeal the tax, H.R. 184, the Protect Medical Innovation Act, that was introduced in January by Rep. Erik Paulsen (R-Minn.) and with the support of more than 220 lawmakers from both parties.